Developing a Positive Approach to Substance Use Prevention in North American Indian Adolescents
Launched by UNIVERSITY OF RHODE ISLAND · May 13, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Developing a Positive Approach to Substance Use Prevention in North American Indian Adolescents," is focused on creating and testing a new program aimed at preventing alcohol, tobacco, and drug use among Native youth. The goal is to make sure the program is culturally relevant and effective for adolescents in grades 5 to 8. Researchers will first gather feedback from both youth and their family members about the program through group discussions. Then, they will test the program with a small group of participants to see how well it works compared to a control group that will not receive the program right away.
To participate in this study, youth must be between 10 and 14 years old, live in a First Nation community, and identify as a member of a First Nation. Additionally, one important adult in their life, who is at least 18 years old and lives in the same community, will also need to join. Participants can expect to attend several sessions where they will discuss their experiences and provide feedback, helping to shape a program that could benefit not only their community but also other Indigenous populations in the future. The trial is currently recruiting participants, and everyone involved will play a key role in making this prevention effort successful.
Gender
ALL
Eligibility criteria
- Inclusion Criteria - Youth Participants:
- • 1. residing in the First Nation community,
- • 2. identify as a member of a First Nation,
- • 3. be in grades 5th - 8th at time of enrollment, and
- • 4. one youth per household may participate.
- Inclusion Criteria - Family Participants:
- • 1. at least 18 years of age
- • 2. reside within the First Nation community
- • 3. be identified, by the youth, as an important influence in their life
- • 4. be committed to helping the youth make good decisions regarding using substances
About University Of Rhode Island
The University of Rhode Island (URI) is a leading academic institution dedicated to advancing research and innovation in health sciences. With a strong commitment to enhancing public health through rigorous clinical trials, URI leverages its multidisciplinary expertise and state-of-the-art facilities to conduct high-quality research. The university fosters collaboration among faculty, students, and healthcare professionals to address pressing medical challenges and improve patient outcomes. By promoting a culture of inquiry and scientific exploration, URI plays a pivotal role in translating research findings into practical applications that benefit communities both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kingston, Rhode Island, United States
Patients applied
Trial Officials
Nichea S Spillane, Ph.D.
Principal Investigator
University of Rhode Island
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials